Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 1:08 AM
NCT ID:
NCT04280393
Eligibility Criteria:
Inclusion Criteria:
A) Patients between the ages of 50 and 70 referred for a colonoscopy within the colorectal cancer screening program.
B) With the ability to provide informed consent
Exclusion Criteria:
1. History of inflammatory bowel disease
2. History or suspected obstruction or intestinal pseudo-obstruction located in the colon
3. History of colon cancer or polyposic syndromes
4. History of colonic stenosis
5. History of severe diverticular segments in some region of the colon
6. Subjects unable to provide informed consent
7. Subjects under treatment with clopidogrel, warfarin, acenocoumarol or other new generation anticoagulants that have not discontinued treatment in accordance with the provisions of these procedures
8. Pregnants females
9. Subjects who are going to undergo a therapeutic or surveillance endoscopy for follow-up of injuries diagnosed in previous procedures
10. Subjects whose baseline status does not allow the completion of the questionnaires necessary for the evaluation of the study objectives.
11. History of previous colonic surgery except for appendectomy
12. Any medical, psychological, psychiatric, geographic or social problem that is important and uncontrolled that may interfere with the patient's participation in the study or that does not allow adequate follow-up and adherence to the protocol and evaluation of the study results.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
70 Years
Study:
NCT04280393
Study Brief:
Protocol Section:
NCT04280393